A hypoxia efficient imidazole-based Ru(ii) arene anticancer agent resistant to deactivation by glutathione1. Issue 13 (7th April 2015) - Purkait, Kallol
Abstract [RuII(η6-p-cym)(L)Cl](PF6) is slow to hydrolyze and shows better anticancer activity in hypoxia with strong resistance to deactivation by l-glutathione.